The CDMO Capacity Crunch With Discovery Labs' Audrey Greenberg and Iovance Biotherapeutics' Sumit Verma
Business Of Biotech
00:00
CDMO Outsourcing - What's the Difference?
There comes a point where as CDMO has become more the status quo. There's an obvious very stark contrast when you go to the board and say, well here's an option. And then assembling this kind of talent is not something you can do in a month or two. Location plays a big role but there's a reason why Silicon Valley becomes such a breeding ground from a make versus partner element. You literally have to be part of that journey with all the players the whole industry is part of it.
Play episode from 18:29
Transcript
